
Holly Auer, MBE
Holly Auer is Senior Vice President of Communications for the American Board of Internal Medicine (ABIM) and the ABIM Foundation, where she leads the organizations' communications strategy, physician engagement, stakeholder communications, social and media relations, and brand management.
A nationally recognized communications leader with deep expertise in health care, academic medicine and scientific communications, Holly joined ABIM after nearly two decades at Penn Medicine, where she served as Associate Vice President for Communications. In that role, she led an award-winning team responsible for media relations, internal communications, publications and strategic storytelling for the University of Pennsylvania Health System and the Perelman School of Medicine.
She directed communications efforts for some of the most significant medical and scientific breakthroughs that are shaping the field today, including the Nobel Prize-winning research that underpins the mRNA COVID-19 vaccines and the development and FDA approval of Kymriah, the first CAR-T cell therapy for cancer. She also led storytelling strategies for major clinical, research and capital project initiatives that advanced Penn Medicine's national and global reputation.
Holly is widely respected for her ability to translate complex scientific and healthcare topics into clear, compelling narratives that engage physicians, media, patients and the public.
Before joining Penn Medicine in 2007, Holly was an award-winning healthcare journalist. She reported for The Buffalo News, The Post and Courier in Charleston, South Carolina, and the Scripps Howard News Service in Washington, D.C. She also contributed to national publications including Glamour, Self and Prevention.
Holly earned an undergraduate degree in magazine journalism from Syracuse University and a master’s degree in bioethics from the University of Pennsylvania. She is a frequent speaker on healthcare communications, research communications, crisis management and reputation strategy.